ENTRY       D00134                      Drug
NAME        Albendazole (JAN/USP/INN);
            Albenza (TN)
PRODUCT     ALBENDAZOLE (Amneal Pharmaceuticals of New York LLC)
            ALBENZA (Amneal Pharmaceuticals LLC)
  GENERIC   ALBENDAZOLE (Actavis Pharma)
            ALBENDAZOLE (AvKARE)
            ALBENDAZOLE (Bryant Ranch Prepack)
            ALBENDAZOLE (Bryant Ranch Prepack)
            ALBENDAZOLE (Bryant Ranch Prepack)
            ALBENDAZOLE (Camber Pharmaceuticals)
            ALBENDAZOLE (Cipla USA)
            ALBENDAZOLE (Dr.Reddys Laboratories)
            ALBENDAZOLE (Edenbridge Pharmaceuticals LLC.)
            ALBENDAZOLE (Golden State Medical Supply)
            ALBENDAZOLE (MSN LABORATORIES PRIVATE LIMITED)
            ALBENDAZOLE (Mark Cuban Cost Plus Drug Company)
            ALBENDAZOLE (Novadoz Pharmaceuticals LLC)
            ALBENDAZOLE (Pharma Packaging Solutions)
            ALBENDAZOLE (Zydus Lifesciences Limited)
            ALBENDAZOLE (Zydus Pharmaceuticals USA)
FORMULA     C12H15N3O2S
EXACT_MASS  265.0885
MOL_WEIGHT  265.3314
REMARK      Same as: C01779
            Therapeutic category: 6429
            ATC code: P02CA03
            Chemical structure group: DG01022
            Product (DG01022): D00134<JP/US>
EFFICACY    Anthelmintic
  DISEASE   Neurocysticercosis [DS:H01047]
            Hydatid disease [DS:H01153]
COMMENT     Benzimidazole derivative
            Inhibiton of microtubule-organizing
TARGET      fumarate reductase
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
              P02 ANTHELMINTICS
               P02C ANTINEMATODAL AGENTS
                P02CA Benzimidazole derivatives
                 P02CA03 Albendazole
                  D00134  Albendazole (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antiparasitics
              Anthelmintics
               Albendazole
                D00134  Albendazole (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              64  Parasitics (systemic)
               642  Anthelmintics
                6429  Others
                 D00134  Albendazole (JAN/USP/INN)
            Antimicrobials [BR:br08307]
             Antiparasitics
              Antinematodal agents
               Benzimidazole derivatives
                D00134  Albendazole (JAN/USP/INN) &lt;JP/US&gt;
DBLINKS     CAS: 54965-21-8
            PubChem: 7847202
            ChEBI: 16664
            LigandBox: D00134
            NIKKAJI: J11.391C
ATOM        18
            1   C8x C    21.9100  -15.5400
            2   C8y C    21.9100  -16.9400
            3   C8x C    23.1700  -17.6400
            4   C8y C    24.3600  -16.9400
            5   C8y C    24.3600  -15.5400
            6   C8x C    23.1700  -14.8400
            7   N5x N    25.6900  -17.3600
            8   C8y C    26.5300  -16.2400
            9   N4x N    25.6900  -15.0500
            10  S2a S    20.7200  -17.6400
            11  C1b C    19.5300  -16.9400
            12  C1b C    18.2700  -17.6400
            13  C1a C    17.0800  -16.9400
            14  N1b N    27.9300  -16.2400
            15  C7a C    28.6300  -17.4300
            16  O7a O    30.0300  -17.4300
            17  C1a C    30.7300  -18.6200
            18  O6a O    27.9300  -18.6200
BOND        19
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    5   9 1
            11    2  10 1
            12   10  11 1
            13   11  12 1
            14   12  13 1
            15    8  14 1
            16   14  15 1
            17   15  16 1
            18   16  17 1
            19   15  18 2
///
